ArticleJournal of neuro-oncology2023

Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk.

Lingyang Hua et al.PubMed ↗Publisher ↗

No numbers read from the abstract.